CLINICAL_TRIALS trial_result · 2024-11-27

Clinical Trial Update: A Phase 1/2 Study to Evaluate Axatilimab in Participants With Active cGVHD [Phase 1, Phase 2]

Results from a Phase 1/2 study of Axatilimab in participants with active chronic graft-versus-host disease have been posted; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Syndax Pharmaceuticals | Conditions: Chronic Graft-versus-host-disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-11-27